Trogocytosis is an endocytic process that is present in many eukaryotes including multicellular organisms and unicellular microbes. Paradoxically, it can be used as a benign form of cell-cell interaction, and it can also be used as a mechanism for cell-mediated killing. Trogocytosis is characterized by ingestion of small pieces of living cells. Additionally, in mammalian immune cells, and in the pathogen Entamoeba histolytica, trogocytosis results in the transfer of membrane proteins from one cell to another. Here, we give a broad overview of trogocytosis, its functions, and proposed molecular mechanisms in different cell types. These studies also reveal trogocytosis as a novel immune evasion mechanism employed by E. histolytica, the parasite responsible for the diarrheal disease amoebiasis. We demonstrate that E. histolytica displays human proteins after performing trogocytosis on human cells, and that this leads to protection from complement lysis. Trophozoites (amoebae) are protected from complement lysis following trogocytosis of live cells but not phagocytosis of dead cells. Amoebic trogocytosis leads to decreased deposition of the complement protein C3b. Furthermore, amoebae acquire and display human CD59 and CD46, which are known negative regulators of the complement pathway. While deletion of one or two complement regulatory proteins from human cells was not sufficient to alter conferred protection, amoebae mutants that exogenously expressed human CD46 or CD55 were protected from lysis. Thus, surface display of an individual negative regulator of complement is sufficient to protect amoebae from lysis. These findings indicate that amoebae likely acquire multiple redundant complement regulators from trogocytosis of human cells which leads to robust protection from complement lysis. Finally, we developed an assay to quantify trogocytosis in mammalian immune cells and generated mutant amoebae trogocytosis and phagocytosis defects. These tools can be used for future study of this important eukaryotic process.
Entamoeba histolytica is a pathogen of global importance, and is responsible for the diarrheal disease amoebiasis. Infection is characterized by massive tissue damage, which is poorly understood and thought to be driven by the contact-dependent cell-killing activity of E. histolytica. E. histolytica performs two main forms of ingestion of human cells: trogocytosis and phagocytosis. Trogocytosis involves taking bites of live host cells and contributes to host cell killing, whereas phagocytosis involves swallowing dead host cells whole. In this body of work, we investigated this distinctions between phagocytosis and trogocytosis, and developed several genetic tools to enable greater study of this parasite. We investigated the connection between host cell attachment and ingestion type by knocking down proteins implicated in attachment using trigger-induced RNA interference. In this process we found that trigger-silenced mutants should be analyzed immediately before phenotypes are lost. We demonstrated for the first time that amoebae acquire and display host cell membrane proteins through trogocytosis but not phagocytosis, allowing them to survive in human serum. To test how host cell deformability influences the type of ingestion performed by amoebae, we designed and optimized an ingestion assay capable of distinguishing between whole host cells, membrane bites, and external host cells. Using this assay, we found that host cells with cytoskeletal proteins knocked down were trogocytosed less by amoebae. We provided practical instruction on how to grow and genetically manipulate E. histolytica in a laboratory research environment. We also constructed the first E. histolytica RNAi knockdown mutant library, and used it to identify and characterize novel genes involved in growth. Finally, we made great progress in establishing CRISPR interference in E. histolytica, discovering that increasing antibiotic concentration affects gene expression, and that a common expression promoter is insufficient for expression of dCas9. Overall, this body of work represents a significant contribution to our understanding of the pathogenesis and cell biology of E. histolytica.
Cookie SettingseScholarship uses cookies to ensure you have the best experience on our website. You can manage which cookies you want us to use.Our Privacy Statement includes more details on the cookies we use and how we protect your privacy.